Advances in Surgery for Benign Prostatic Hyperplasia

Benign prostatic hyperplasia (BPH) is most commonly observed in men of advancing age. Patients with BPH may experience urinary symptoms. For moderate lower urinary tract symptoms (LUTS), pharmacotherapy is recommended, but many patients have symptom progression and require additional surgical intervention such as transurethral resection of prostate (TURP) or prostatectomy. However, these procedures are still associated with significant perioperative morbidity. As a result, treatment-related complications have led to the development of new technologies for the management of BPH.